Vitamin D effects in asthma
Not Applicable
- Conditions
- Asthma.Asthma
- Registration Number
- IRCT201302079608N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Age 10-50;
Asthma diagnosis according to spirometry and GINA guidlines;
Ruled out of COPD and any chronic lung diseases;
No asthma attack in previous 3 months;
No pregnancy;
No malignancy; sarcoidosis; renal or intestinal diseases or hyper sensitivity to vitamin D;
No use of systemic corticoesteroid or anti convulsant
Exclusion criteria
No inclusion criteria;
No consent to this program
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Airway function. Timepoint: Before and after 8week, 16 week and after 6month. Method of measurement: Oscilometry.;Airway function. Timepoint: Before and after 8week, 16 week and after 6month. Method of measurement: Spirometry.;Serum vitamin D level. Timepoint: Before and after 8week, 16 week and after 6month. Method of measurement: eliza (serum).
- Secondary Outcome Measures
Name Time Method Serume Ig E level. Timepoint: before and after study. Method of measurement: ELIZA.